Determining Predictors of Sensitivity to CHK Inhibitors in Metastatic Melanoma (Cancer Australia grant administered by the University of Melbourne) (2012-2015)
Experts
Professor
Brian Gabrielli
Honorary Professor
Mater Research Institute-UQ
Faculty of Health, Medicine and Behavioural Sciences